Impact of Cigarette and E-cigarette Menthol Regulation on Current Smokers of Menthol Cigarettes

March 4, 2026 updated by: Tracy Smith, Medical University of South Carolina

The Impact of Menthol Regulation for Cigarettes and E-cigarettes on Tobacco Use Patterns for Current Menthol Smokers

In a 2x2 design, current menthol smokers (N=240) will complete a baseline period before being assigned to a cigarette (menthol or non-menthol) and e-cigarette condition (menthol or tobacco-flavored e-liquid) and receiving a 7-week supply of cigarettes and e-cigarettes. The study builds upon our well-established methodology for simulating tobacco regulatory policies. To model a ban, smokers will be instructed to only use their assigned products. Primary outcomes include cigarette smoking and e-cigarette use during Week 6. However, because a menthol ban may impact the ability to abstain from smoking, the investigators will incentivize participants to abstain from smoking during Week 7 (continued e-cigarette use allowed) and assess the time to first lapse. Participants will complete daily electronic diaries assessing tobacco product use throughout, which will be corroborated by biomarkers for menthol, nicotine, and smoke. Finally, to maximize the utility of these data for FDA regulation, the investigators will assess whether any demographic or baseline smoking characteristics moderate the observed treatment effects, calibrate the treatment effects to the US adult menthol smoking population, and model the effects of menthol regulation in cigarettes and e-cigarettes on smoking and vaping-attributable deaths and life-years lost.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

240

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • South Carolina
      • Charleston, South Carolina, United States, 29425
        • Recruiting
        • Medical University of South Carolina
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. adults (21+) who a) have been smoking at least 5 cigarettes daily for one year
  2. usual brand (the brand used most often) is mentholated
  3. have a smartphone that can receive text messages and access the internet (necessary for diary completion).

Exclusion Criteria:

  1. other tobacco and pharmacotherapy criteria
  2. health and safety criteria
  3. planning to move out of the area within the next 3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Menthol Spectrum Cigarettes and Menthol E-cigarettes
Ppts will be randomly assigned to receive the menthol spectrum cigarettes and Njoy Ace menthol e-cigarettes. Will be used for the duration of the study (8 weeks) starting at the second visit.
Ppts will be randomly assigned to a group that receives menthol flavored cigarettes
Ppts will be randomly assigned to a group that receives menthol flavored e-cigarettes
Experimental: Menthol Spectrum Cigarettes and Tobacco E-cigarettes
Ppts will be randomly assigned to receive the menthol spectrum cigarettes and Njoy Ace tobacco e-cigarettes. Will be used for the duration of the study (8 weeks) starting at the second visit.
Ppts will be randomly assigned to a group that receives menthol flavored cigarettes
Ppts will be randomly assigned to a group that receives tobacco flavored e-cigarettes
Experimental: Non-menthol Spectrum Cigarettes and Menthol E-cigarettes
Ppts will be randomly assigned to receive the non-menthol spectrum cigarettes and Njoy Ace menthol e-cigarettes. Will be used for the duration of the study (8 weeks) starting at the second visit.
Ppts will be randomly assigned to a group that receives menthol flavored e-cigarettes
Ppts will be randomly assigned to a group that receives non-menthol cigarettes
Experimental: Non-menthol Spectrum Cigarettes and Tobacco E-cigarettes
Ppts will be randomly assigned to receive the non-menthol spectrum cigarettes and Njoy Ace tobacco e-cigarettes. Will be used for the duration of the study (8 weeks) starting at the second visit.
Ppts will be randomly assigned to a group that receives tobacco flavored e-cigarettes
Ppts will be randomly assigned to a group that receives non-menthol cigarettes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in cigarettes per day
Time Frame: Week 1- Week 6
Will be measured through week 6 of the study
Week 1- Week 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fagerstrom Test for Nicotine Dependence
Time Frame: Week 1- Week 7
Cigarette Dependence
Week 1- Week 7
Ability to abstain from smoking
Time Frame: Week 7
Participants will complete a 1-week practice quit attempt in week 7; time to first smoking lapse will be assessed.
Week 7

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 23, 2023

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

August 31, 2027

Study Registration Dates

First Submitted

May 19, 2023

First Submitted That Met QC Criteria

May 30, 2023

First Posted (Actual)

June 9, 2023

Study Record Updates

Last Update Posted (Actual)

March 5, 2026

Last Update Submitted That Met QC Criteria

March 4, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 00122898
  • 1R01DA055985-01A1 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Prevention and Control

Clinical Trials on Menthol Cigarettes

Subscribe